Boston Scientific Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Well, good morning, everyone, and welcome to day 3 of the Morgan Stanley healthcare conference 2020. My name is David Lewis, medical device analyst at Morgan Stanley, and thanks for your -- for joining us bright and early, earlier for me than for you on the East Coast.
It's my pleasure to kind of kick off day 3 here with one of our large-cap companies, Boston Scientific. We have both their CEO, Michael Mahoney; as well as their CFO, Dan Brennan. Pleased to have you both this morning.
And with that, we're ready for action.
Questions & Answers
So team, I thought we'd start off where I'd been starting off kind of all week and just talk about COVID-19 recovery, your thoughts and anything you're willing to share here post the quarter. How have month-on-month trends been here in the third quarter? Most of our companies have talked about kind of nice sequential month-on-month improvement. I just wondered if you could comment
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
